Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.

Han X, Vesely MD, Yang W, Sanmamed MF, Badri T, Alawa J, López-Giráldez F, Gaule P, Lee SW, Zhang JP, Nie X, Nassar A, Boto A, Flies DB, Zheng L, Kim TK, Moeckel GW, McNiff JM, Chen L.

Sci Transl Med. 2019 Dec 11;11(522). pii: eaax1159. doi: 10.1126/scitranslmed.aax1159.

PMID:
31826980
2.

Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib.

Damsky WE, Vesely MD, Lee AI, Choi J, Meyer AC, Chen M, Ahmad T, King B.

JAAD Case Rep. 2019 Nov 13;5(12):1018-1026. doi: 10.1016/j.jdcr.2019.07.004. eCollection 2019 Dec. No abstract available.

3.

Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.

Han X, Vesely MD.

Int Rev Cell Mol Biol. 2019;342:1-25. doi: 10.1016/bs.ircmb.2018.07.003. Epub 2018 Aug 20. Review.

4.

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis.

Vesely MD, Imaeda S, King BA.

JAAD Case Rep. 2016 Dec 21;3(1):4-6. doi: 10.1016/j.jdcr.2016.09.008. eCollection 2017 Jan. No abstract available.

5.

A Serendipitous Retreat into Research Techniques Made Simple.

Vesely MD.

J Invest Dermatol. 2016 Dec;136(12):e123. doi: 10.1016/j.jid.2016.10.009. No abstract available.

6.

Recurrent Coxsackievirus Infection in a Patient with Lamellar Ichthyosis.

Damsky WE, Leventhal JS, Khalil D, Vesely MD, Craiglow BG, Milstone LM, Choate KA.

Pediatr Dermatol. 2016 Mar-Apr;33(2):e140-2. doi: 10.1111/pde.12769. Epub 2016 Jan 29.

PMID:
26821985
7.

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD.

Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988.

8.

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.

Vesely MD, Schreiber RD.

Ann N Y Acad Sci. 2013 May;1284:1-5. doi: 10.1111/nyas.12105.

9.

Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state.

Teng MW, Vesely MD, Duret H, McLaughlin N, Towne JE, Schreiber RD, Smyth MJ.

Cancer Res. 2012 Aug 15;72(16):3987-96. doi: 10.1158/0008-5472.CAN-12-1337. Epub 2012 Aug 6.

10.

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.

Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD.

Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755.

11.

Natural innate and adaptive immunity to cancer.

Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ.

Annu Rev Immunol. 2011;29:235-71. doi: 10.1146/annurev-immunol-031210-101324. Review.

PMID:
21219185
12.

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.

Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):652-6. doi: 10.1073/pnas.0708594105. Epub 2008 Jan 4.

13.

Evidence for an atrial natriuretic peptide-like gene in plants.

Vesely MD, Gower WR Jr, Perez-Lamboy G, Overton RM, Graddy L, Vesely DL.

Exp Biol Med (Maywood). 2001 Jan;226(1):61-5.

PMID:
11368240
14.

Environmental upregulation of the atrial natriuretic peptide gene in the living fossil, Limulus polyphemus.

Vesely MD, Vesely DL.

Biochem Biophys Res Commun. 1999 Jan 27;254(3):751-6.

PMID:
9920813

Supplemental Content

Loading ...
Support Center